SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a blowout earnings report and raised guidance that highlighted strong momentum in data center and AI-driven demand. The community is actively debating whether this explosive rally marks the start of a generational growth phase or a speculative bubble, with many traders discussing potential short squeezes and aggressive price targets.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed bullish sentiment as the stock recovers from lows, fueled by evidence that its oral Wegovy prescriptions are outpacing Eli Lilly's recent weight-loss pill launch and a favorable ruling by the FDA regarding compounded alternatives. Investors are increasingly optimistic that Novos established distribution, competitive pricing, and upcoming Medicare coverage will drive a strong rebound, with many pointing to a compelling valuation as the stock re-rates from recent sell-offs.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging in after-hours trading as investors prioritize the company's significant margin recovery and upbeat forward guidance over a reported revenue miss. The community is actively debating the stock's massive short interest and potential for a squeeze, with many long-term holders pointing to its low valuation relative to AI peers as a catalyst for a sustained rerating.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is experiencing a massive parabolic rally fueled by a structural supercycle in AI-driven memory demand and a persistent supply shortage. The community remains deeply divided, with bulls pointing to fundamental re-rating and order growth while bears express significant concern over speculative euphoria and the sustainability of the current price levels.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing massive bullish momentum driven by insatiable AI-driven demand for memory chips and data center storage, leading to intense speculative trading and record-setting options volume. Community sentiment is overwhelmingly bullish, with many investors viewing the stock as a long-term leader in the AI infrastructure supercycle despite its significant year-to-date appreciation.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying following a massive $1.1 billion AI colocation agreement with Cerebras Systems, fueling community optimism about its role as a validated data center infrastructure provider. While bullish traders are focused on the long-term revenue visibility and upcoming Cerebras IPO as key catalysts, others remain cautious of high volatility and potential dilution.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as investors focus on its privacy narrative and recent integration into major trading platforms, sparking community debates about its potential as a long-term store of value. Sentiment remains highly polarized, with many users speculating on supply dynamics and institutional interest while others caution against volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Investors are closely monitoring ImmunityBio as the stock builds momentum ahead of upcoming earnings and key data presentations, with community discussion centered on potential global expansion and intense frustration toward the high short interest. Speculation is high that recent executive communications and international travel signal a major catalyst or deal that could challenge the current regulatory gridlock in the U.S.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention following positive Phase 2 trial results for its lead skin disease drug, with the community closely tracking the company's subsequent public offering and the potential for a short squeeze. Despite concerns regarding dilution, investors remain focused on the clinical progress and the possibility of further price momentum as the company advances its pipeline.

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

Transmedics Group is attracting significant attention as investors react to robust flight data and strategic infrastructure expansion, fueling confidence in its long-term market dominance. The community is actively discussing the stock's resilience, recent insider buying, and the potential for a breakout as the company scales its unique organ preservation technology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DOJ confirms antitrust probe into the 4 biggest U.S. beef processors

The four companies JBS, National Beef, Cargill, and Tyson Foods control more than 85% of U.S. beef processing...

JBS (JBSAY) to Release Earnings on Monday

JBS (OTCMKTS:JBSAY) will be releasing earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-jbs-sa-stock...

DOJ confirms antitrust probe of major meatpackers over beef price inflation

The Justice Department confirmed its active investigation of potential antitrust violations in U.S. cattle and beef markets, reviewing more than 3 million documents and interviewing industry...

Mitsubishi UFJ Trust & Banking Corp Reduces Stock Holdings in Jbs N.V. $JBS

Mitsubishi UFJ Trust & Banking Corp trimmed its position in Jbs N.V. (NYSE:JBS - Free Report) by 46.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 197,676 shares of the company's stock after selling 169,164 shares during the period. Mitsubishi U...

Davis Selected Advisers Takes $170.95 Million Position in Jbs N.V. $JBS

Davis Selected Advisers purchased a new stake in shares of Jbs N.V. (NYSE:JBS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 11,854,741 shares of the company's stock, valued at approximately $170,945,000. Several other...

Wall Street Zen Downgrades John B. Sanfilippo & Son (NASDAQ:JBSS) to Buy

Wall Street Zen cut John B. Sanfilippo & Son from a "strong-buy" rating to a "buy" rating in a research note on Saturday...

John B. Sanfilippo & Son Q3 Earnings Call Highlights

John B. Sanfilippo & Son (NASDAQ:JBSS) reported fiscal third-quarter 2026 results highlighted by record net sales growth driven primarily by higher pricing, while profitability declined year over...

John B. Sanfilippo & Son (NASDAQ:JBSS) Releases Earnings Results, Beats Estimates By $0.27 EPS

John B. Sanfilippo & Son (NASDAQ:JBSS - Get Free Report) announced its earnings results on Wednesday. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.16 by...

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for JBS (NYSE:JBS) Stock

JPMorgan Chase & Co. raised their price objective on JBS from $20.00 to $20.50 and gave the company an "overweight" rating in a research note on Friday...

John B. Sanfilippo & Son (JBSS) Projected to Post Quarterly Earnings on Wednesday

John B. Sanfilippo & Son (NASDAQ:JBSS) will be releasing its Q3 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at...

JBS NV is a food company that engages in the sale of beef, pork, lamb meat and poultry products. It offers its products to supermarkets, club stores, other retail distributors, and foodservice companies. The company was founded on October 9, 2019 and is headquartered in Amstelveen, the Netherlands.

JBS N.V. - Ordinary Shares - Class A

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.20	--	--	N/A
Q4 '25	$0.41	$0.39	-4.32%	MISSED
Q3 '25	$0.50	$0.52	4.62%	BEAT
Q2 '25	$0.48	$0.53	11.10%	BEAT

JBS
JBS N.V. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest JBS News

JBSJBS N.V. - Ordinary Shares - Class A